---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-23-000010"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T05:02:29.529883+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Haemonetics reports Q4 and FY2023 results; specific figures not available

## Summary
- Reported financial results for quarter and fiscal year ended April 1, 2023.
- Press release issued on May 11, 2023, but no financial details provided in filing.
- Unable to extract revenue, EPS, or segment performance from available text.

## SEC filing metadata
- accession: 0000313143-23-000010
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314323000010/0000313143-23-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314323000010/hae-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-23-000010
- JSON: https://secwatch.observer/filing/0000313143-23-000010.json
- Plain text: https://secwatch.observer/filing/0000313143-23-000010.txt

## Key facts
- Earnings Releases
  HAEMONETICS CORP reported financial results for the fourth quarter and fiscal year ended April 1, 2023.
  - Period: the fourth quarter and fiscal year ended April 1, 2023
  - Result: reported results
  source text: On May 11, 2023 , Haemonetics Corporation issued a press release announcing financial results for the fourth quarter and fiscal year ended April 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314323000010/0000313143-23-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.